Featured Nov 3, 2024 Autonomous Therapeutics and Mink Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors Nov 3, 2024 Nov 3, 2024 Nov 3, 2024 Autonomous CEO, Dr. Ariel Weinberger, serves on keynote panel at World Vaccine & Immunotherapy Congress Nov 3, 2024 Nov 3, 2024 Nov 3, 2024 Autonomous CEO, Dr. Ariel Weinberger, gives plenary presentation at NIH Synthetic Biology Consortium Meeting Nov 3, 2024 Nov 3, 2024 Nov 3, 2024 Autonomous Therapeutics wins $1 million Blue Knight™ QuickFire Challenge Nov 3, 2024 Nov 3, 2024 Sep 19, 2023 Keynote Panel @ RNA Leaders USA Congress Sep 19, 2023 Sep 19, 2023 Apr 15, 2023 Op-Ed in BioCentury: The urgent need for variant-proof therapeutics Apr 15, 2023 Apr 15, 2023 Apr 15, 2023 Autonomous Therapeutics, CEO, Dr. Ariel Weinberger, interviewed by Vaccine Nation about next-generation mRNA therapeutics and antivirals Apr 15, 2023 Apr 15, 2023 Nov 21, 2021 Autonomous CEO, Dr. Ariel Weinberger, presents on novel mRNA therapeutic technologies at the World Antiviral Congress Nov 21, 2021 Nov 21, 2021 Jan 19, 2021 BioBuzz Interviews Autonomous Therapeutics CEO Ariel Weinberger Jan 19, 2021 Jan 19, 2021 Oct 19, 2020 Antiviral drug company working on Covid-19 relocates to Rockville Oct 19, 2020 Oct 19, 2020
